483
Philip NMI RaskinPhilip NMI Raskin – FDA 483, Jan 11, 2024
Record Details
An FDA inspection of Philip NMI Raskin, MD, Clinical Investigator in Dallas, TX, revealed that an investigation was not conducted in accordance with the investigational plan. Specifically, the study drug was not suspended for subjects experiencing adverse events as required by the protocol. This indicates a significant deviation from established study procedures.
View Company Profile
ID · 409f2a22-c835-4ea3-a8ed-4bc4a0b41d36
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.